Old Web
English
Sign In
Acemap
>
authorDetail
>
Mohammad Hojat Farsangi
Mohammad Hojat Farsangi
Karolinska University Hospital
ROR1
Receptor tyrosine kinase
Pathology
Cancer research
Medicine
2
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells.
2017
Journal of Clinical Oncology
Mohammad Hojat Farsangi
Fatemeh Ghaemimanesh
Amir Hossein Daneshmanesh
Ali Ahmad Bayat
Jafar Mahmoudian
Mahmood Jeddi-Tehrani
Håkan Mellstedt
Show All
Source
Cite
Save
Citations (0)
Effect of ROR1-targeting small molecules on chronic lymphocytic leukemia (CLL) cells.
2017
Journal of Clinical Oncology
Håkan Mellstedt
Salam Khan
Jan Vågberg
Styrbjörn Byström
Johan Schultz
Mohammad Hojat Farsangi
Ladan Mansouri
Amir Hossein Danesh-Manesh
Anders Österborg
Ali Moshfegh
Show All
Source
Cite
Save
Citations (7)
1